Selinexor in advanced, metastatic dedifferentiated liposarcoma: a multinational, randomized, double-blind, placebo-controlled trial - Gounder, Mrinal M.; Razak, Albiruni Abdul; Somaiah, Neeta; Chawla, Sant; Martin-Broto, Javier; Grignani, Giovanni; Schuetze, Scott M.; Vincenzi, Bruno; Wagner, Andrew J.; Chmielowski, Bartosz; Jones, Robin L.; Riedel, Richard F.; et al. (Journal of clinical oncology, 2022)
Gesehen am 15.11.2022